599 related articles for article (PubMed ID: 17849461)
41. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
[TBL] [Abstract][Full Text] [Related]
42. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.
Al-Mulla F; Hagan S; Behbehani AI; Bitar MS; George SS; Going JJ; García JJ; Scott L; Fyfe N; Murray GI; Kolch W
J Clin Oncol; 2006 Dec; 24(36):5672-9. PubMed ID: 17179102
[TBL] [Abstract][Full Text] [Related]
43. [Expression of COX-2 protein in colorectal carcinoma and the clinical implication].
Yao HB; Wu AG; Chen YJ; Tang BH
Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1524-8. PubMed ID: 16361154
[TBL] [Abstract][Full Text] [Related]
44. CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancer.
Ahmed MA; Al-Attar A; Kim J; Watson NF; Scholefield JH; Durrant LG; Ilyas M
J Clin Pathol; 2009 Dec; 62(12):1117-22. PubMed ID: 19946098
[TBL] [Abstract][Full Text] [Related]
45. Significance of p-STAT3 expression in human colorectal adenocarcinoma.
Park JK; Hong R; Kim KJ; Lee TB; Lim SC
Oncol Rep; 2008 Sep; 20(3):597-604. PubMed ID: 18695911
[TBL] [Abstract][Full Text] [Related]
46. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.
Zheng HC; Xia P; Xu XY; Takahashi H; Takano Y
Hum Pathol; 2011 Mar; 42(3):424-33. PubMed ID: 21193223
[TBL] [Abstract][Full Text] [Related]
47. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
48. Expression of standard CD44 in human colorectal carcinoma: association with prognosis.
Huh JW; Kim HR; Kim YJ; Lee JH; Park YS; Cho SH; Joo JK
Pathol Int; 2009 Apr; 59(4):241-6. PubMed ID: 19351367
[TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
[TBL] [Abstract][Full Text] [Related]
50. ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival.
Weichert W; Knösel T; Bellach J; Dietel M; Kristiansen G
J Clin Pathol; 2004 Nov; 57(11):1160-4. PubMed ID: 15509676
[TBL] [Abstract][Full Text] [Related]
51. Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression.
Toyoda A; Kawana H; Azuhata K; Yu J; Omata A; Kishi H; Higashi M; Harigaya K
Int J Oncol; 2009 Jan; 34(1):53-60. PubMed ID: 19082477
[TBL] [Abstract][Full Text] [Related]
52. An early evaluation of malignant tendency with plectin expression in human colorectal adenoma and adenocarcinoma.
Lee KY; Liu YH; Ho CC; Pei RJ; Yeh KT; Cheng CC; Lai YS
J Med; 2004; 35(1-6):141-9. PubMed ID: 18084872
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
[TBL] [Abstract][Full Text] [Related]
54. Role and prognostic significance of CD44s expression in colorectal cancer.
Visca P; Del Nonno F; Botti C; Marandino F; Sebastiani V; Di Tondo U; Donnorso RP; Trombetta G; Filippi S; Alo PL
Anticancer Res; 2002; 22(5):2671-5. PubMed ID: 12529980
[TBL] [Abstract][Full Text] [Related]
55. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
[TBL] [Abstract][Full Text] [Related]
56. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.
Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y
Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358
[TBL] [Abstract][Full Text] [Related]
57. Akt phosphorylates and regulates Pdcd4 tumor suppressor protein.
Palamarchuk A; Efanov A; Maximov V; Aqeilan RI; Croce CM; Pekarsky Y
Cancer Res; 2005 Dec; 65(24):11282-6. PubMed ID: 16357133
[TBL] [Abstract][Full Text] [Related]
58. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
Karamitopoulou E; Zlobec I; Panayiotides I; Patsouris ES; Peros G; Rallis G; Lapas C; Karakitsos P; Terracciano LM; Lugli A
Hum Pathol; 2011 Dec; 42(12):1888-96. PubMed ID: 21664646
[TBL] [Abstract][Full Text] [Related]
59. Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival.
Kim H; Kang HJ; You KT; Kim SH; Lee KY; Kim TI; Kim C; Song SY; Kim HJ; Lee C; Kim H
Proteomics; 2006 Jun; 6(11):3466-76. PubMed ID: 16645984
[TBL] [Abstract][Full Text] [Related]
60. [Immunohistochemical expression of p53 oncoprotein in large bowel adenomas and carcinomas].
Roa JC; Villaseca MA; Roa I; Araya JC; Okayasu I; Flores P; Flores M
Rev Med Chil; 1997 May; 125(5):523-9. PubMed ID: 9497572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
